Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II single-arm study of IMOD in adults with HIV infection receiving HAART
IRCT138904084272N1Phase 2Completed
- Sponsor
- Pars Roos
- Start
- Jul 2010
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of IMOD in human immunodeficiency virus infection (HIV), acquired immunodeficiency syndrome (AIDS), sponsored by Pars Roos. Started Jul 2010; status: completed.
02
Drugs
IMOD
03
Conditions
human immunodeficiency virus infection (HIV)acquired immunodeficiency syndrome (AIDS)
Beyond the preview
Go deeper on IRCT138904084272N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138904084272N1.